Verici Dx (VRCI) Competitors

Verici Dx (LON:VRCI) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Which has more risk & volatility, VRCI or AGL?

Verici Dx has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500.

Which has preferable valuation & earnings, VRCI or AGL?

Verici Dx has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	£3.34M	2.27	-£6.56M	-£0.03	-20.00
ANGLE	£2.62M	3.95	-£21.76M	-£0.05	-66.60

Does the media prefer VRCI or AGL?

In the previous week, ANGLE had 1 more articles in the media than Verici Dx. MarketBeat recorded 1 mentions for ANGLE and 0 mentions for Verici Dx. ANGLE's average media sentiment score of 0.44 beat Verici Dx's score of 0.00 indicating that ANGLE is being referred to more favorably in the news media.

Company	Overall Sentiment
Verici Dx	Neutral
ANGLE	Neutral

Do insiders & institutionals hold more shares of VRCI or AGL?

15.9% of Verici Dx shares are owned by institutional investors. Comparatively, 17.5% of ANGLE shares are owned by institutional investors. 1.0% of Verici Dx shares are owned by insiders. Comparatively, 2.7% of ANGLE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is VRCI or AGL more profitable?

Verici Dx has a net margin of -110.99% compared to ANGLE's net margin of -890.91%. Verici Dx's return on equity of -71.67% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	-110.99%	-71.67%	-26.14%
ANGLE	-890.91%	-76.01%	-29.89%

Do analysts prefer VRCI or AGL?

ANGLE has a consensus price target of GBX 40, suggesting a potential upside of 1,146.11%. Given ANGLE's stronger consensus rating and higher possible upside, analysts clearly believe ANGLE is more favorable than Verici Dx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Verici Dx	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
ANGLE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Verici Dx and ANGLE tied by winning 8 of the 16 factors compared between the two stocks.